awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35584962-0BC7F6EB-B2CF-49CA-8E4F-0E0814EA855A
Q35584962-0BC7F6EB-B2CF-49CA-8E4F-0E0814EA855A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35584962-0BC7F6EB-B2CF-49CA-8E4F-0E0814EA855A
Combining emerging agents in advanced breast cancer
P2860
Q35584962-0BC7F6EB-B2CF-49CA-8E4F-0E0814EA855A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35584962-0BC7F6EB-B2CF-49CA-8E4F-0E0814EA855A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5eef2debdf39b899484b85049df83330c9ef5dba
P2860
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study